+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating the combination of baxdrostat and dapagliflozin compared with dapagliflozin alone in adults aged 40 years and older who have type 2 diabetes, established cardiovascular disease, a history of hypertension with elevated systolic blood pressure, and at least one additional risk factor for heart failure. This phase III trial aims to assess whether adding baxdrostat can reduce the risk of heart failure events or cardiovascular death. Participants will be randomly assigned to receive either baxdrostat with dapagliflozin or placebo with dapagliflozin. Those not currently on SGLT2 inhibitors or treated for less than 4 weeks will enter a run-in period taking dapagliflozin alone for 4 to 6 weeks before randomization. Doses of baxdrostat may be increased if criteria are met. Study visits occur at 2, 4, 8, 16, and 34 weeks after randomization and then approximately every 4 months until the study ends when enough cardiovascular events have occurred. During the study, participants will have regular assessments including blood pressure and laboratory tests to monitor safety and efficacy. If participants stop the blinded study treatment early, they may continue open-label dapagliflozin. The main outcome is to see if the combination reduces heart failure events or cardiovascular death compared to dapagliflozin alone, with follow-up lasting up to 38 months. Data collection and scheduled visits will continue throughout the study period.

Age: 40Years +All GendersPhase 3
977 locations
C

Actively Recruiting

This research aims to find out if a self-administered Pap smear test by the patient is as accurate as the traditional Pap smear performed by a healthcare provider. The study involves women aged 21 to 65 who need routine cervical cancer screening, focusing on improving screening rates in rural Alabama. It is an interventional study sponsored by the University of Alabama at Birmingham, comparing two methods of Pap smear collection. Participants will perform a self-collected Pap smear on the day of their clinical examination, followed by a traditional Pap smear collected by a licensed healthcare provider such as a physician, nurse practitioner, or physician assistant. Both samples will be labeled separately and sent to a clinical laboratory for blinded analysis to compare their accuracy. During the study, participants will have specimens collected during a single clinical visit. The laboratory will analyze both the self-collected and provider-collected samples without knowing which is which. Results will be shared with participants through usual clinical practice. The primary outcome measured is the agreement and accuracy between the self-collected Pap smear and the traditional Pap smear within 14 days after collection.

Age: 21Years - 65YearsFEMALEPhase Not Applicable
3 locations